Avantor
Avantor, Inc., a leading global provider of mission-critical products and services, is headquartered in the United States. Founded in 1904, the company has established a strong presence in the life sciences and advanced technologies sectors, serving customers across various industries, including pharmaceuticals, biotechnology, and education. With a diverse portfolio that includes high-quality laboratory supplies, chemicals, and custom manufacturing solutions, Avantor distinguishes itself through its commitment to innovation and customer-centric approach. The company has achieved significant milestones, including strategic acquisitions that have expanded its operational footprint in key regions worldwide. Recognised for its market leadership, Avantor continues to drive advancements in scientific research and development, making it a trusted partner for organisations seeking reliable and efficient solutions in the ever-evolving landscape of science and technology.
DitchCarbon Score
How does Avantor's carbon action stack up? DitchCarbon scores companies based on their carbon action and commitment to reducing emissions. Read about our methodology to learn more.
Industry Average
Mean score of companies in the Research Services industry. Comparing a company's score to the industry average can give you a sense of how well the company is doing compared to its peers.
Industry Benchmark
Avantor's score of 35 is higher than 92% of the industry. This can give you a sense of how well the company is doing compared to its peers.
Let us know if this data was useful to you
Avantor's reported carbon emissions
In 2023, Avantor reported total greenhouse gas emissions of approximately 55,028,000 kg CO2e, comprising about 26,095,000 kg CO2e from Scope 1 and about 28,933,000 kg CO2e from Scope 2 emissions. This reflects a slight decrease from 2022, where total emissions were about 57,847,000 kg CO2e, with Scope 1 at approximately 25,340,000 kg CO2e and Scope 2 at around 32,507,000 kg CO2e. Avantor has set a significant commitment to reduce its Scope 1 and Scope 2 greenhouse gas emissions by 15% by 2025, starting from a baseline year of 2019. This target underscores the company's proactive approach to climate action within the pharmaceuticals, biotechnology, and life sciences sector. As of now, Avantor has not disclosed any Scope 3 emissions data, indicating a focus on direct and indirect emissions from its operations and energy use. The company's emissions reduction initiatives are part of a broader commitment to sustainability, aligning with industry standards and expectations for corporate responsibility in addressing climate change.
Unlock detailed emissions data
Access structured emissions data, company-specific emission factors, and source documents
| 2019 | 2020 | 2021 | 2022 | 2023 | |
|---|---|---|---|---|---|
| Scope 1 | 27,871,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 2 | 38,194,000 | 00,000,000 | 00,000,000 | 00,000,000 | 00,000,000 |
| Scope 3 | - | - | - | - | - |
Industry emissions intensity
Location emissions intensity
Reduction initiatives & disclosure networks
Companies disclose and commit to reducing emissions to show they are serious about reducing emissions impact over time. They can also help a company track its progress over time.
Avantor is participating in some of the initiatives that we track. This may change over time as the company engages with new initiatives or updates its commitments. DitchCarbon will update this information as it becomes available.
